---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033593"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-07-16T21:30:15+00:00"
generated_at: "2026-07-16T21:32:07.348898+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BioRestorative CEO and CFO resign; board appoints new CEO, investigates employment agreements

## Summary
- CEO Lance Alstodt and CFO Robert Kristal resigned July 13, 2026, claiming 'Good Reason' under alleged Change in Control; seek ~$2.85M aggregate severance plus equity acceleration.
- Board appointed director Katharyn Field as CEO, President, and interim CFO; she also serves as CEO of iSpecimen (ISPC).
- Board elected Esha Randhawa and Steven Brown as new directors; committees reconstituted with new chairs.
- Board authorized investigation into negotiation and approval of employment agreements; no severance payments pending outcome.
- Employment agreements amended July 8, 2026 to limit change-in-control severance to only certain transaction types.

## SEC filing metadata
- accession: 0001493152-26-033593
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-07-16T21:30:15+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000149315226033593/0001493152-26-033593-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000149315226033593/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033593
- JSON: https://secwatch.observer/filing/0001493152-26-033593.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033593.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.